

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.06889787 |
| 2 | protein neddylation (GO:0045116) | 5.76457612 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 5.61688039 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.61688039 |
| 5 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.53875525 |
| 6 | protein complex biogenesis (GO:0070271) | 5.18229796 |
| 7 | respiratory electron transport chain (GO:0022904) | 5.16048160 |
| 8 | sequestering of actin monomers (GO:0042989) | 5.10575269 |
| 9 | electron transport chain (GO:0022900) | 5.07060280 |
| 10 | platelet dense granule organization (GO:0060155) | 4.76376022 |
| 11 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.42248315 |
| 12 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.23074085 |
| 13 | DNA deamination (GO:0045006) | 4.05003571 |
| 14 | chaperone-mediated protein transport (GO:0072321) | 4.03805918 |
| 15 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.03331509 |
| 16 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.03331509 |
| 17 | NADH dehydrogenase complex assembly (GO:0010257) | 4.03331509 |
| 18 | ribosomal small subunit assembly (GO:0000028) | 3.98094473 |
| 19 | cytidine deamination (GO:0009972) | 3.97702648 |
| 20 | cytidine metabolic process (GO:0046087) | 3.97702648 |
| 21 | cytidine catabolic process (GO:0006216) | 3.97702648 |
| 22 | viral transcription (GO:0019083) | 3.91326080 |
| 23 | protein targeting to ER (GO:0045047) | 3.73901721 |
| 24 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.73896859 |
| 25 | cotranslational protein targeting to membrane (GO:0006613) | 3.71544622 |
| 26 | protein localization to endoplasmic reticulum (GO:0070972) | 3.66384943 |
| 27 | translational termination (GO:0006415) | 3.65700704 |
| 28 | hydrogen ion transmembrane transport (GO:1902600) | 3.62627026 |
| 29 | eosinophil chemotaxis (GO:0048245) | 3.58960606 |
| 30 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.57442977 |
| 31 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.56945205 |
| 32 | cytochrome complex assembly (GO:0017004) | 3.41271495 |
| 33 | proton transport (GO:0015992) | 3.31670617 |
| 34 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.31336797 |
| 35 | behavioral response to nicotine (GO:0035095) | 3.27589985 |
| 36 | hydrogen transport (GO:0006818) | 3.25201225 |
| 37 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.22702866 |
| 38 | eosinophil migration (GO:0072677) | 3.19879541 |
| 39 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.19078387 |
| 40 | ATP biosynthetic process (GO:0006754) | 3.15770877 |
| 41 | translational elongation (GO:0006414) | 3.13895659 |
| 42 | positive regulation of TOR signaling (GO:0032008) | 3.09508803 |
| 43 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.02863812 |
| 44 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.98877230 |
| 45 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.98458914 |
| 46 | viral life cycle (GO:0019058) | 2.97521057 |
| 47 | iron-sulfur cluster assembly (GO:0016226) | 2.94634388 |
| 48 | metallo-sulfur cluster assembly (GO:0031163) | 2.94634388 |
| 49 | ribosomal small subunit biogenesis (GO:0042274) | 2.87065151 |
| 50 | cellular response to zinc ion (GO:0071294) | 2.82709809 |
| 51 | proteasome assembly (GO:0043248) | 2.79856528 |
| 52 | protein maturation by protein folding (GO:0022417) | 2.78791242 |
| 53 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.77418797 |
| 54 | cellular protein complex disassembly (GO:0043624) | 2.74854106 |
| 55 | regulation of cilium movement (GO:0003352) | 2.74715791 |
| 56 | deoxyribonucleotide catabolic process (GO:0009264) | 2.74245079 |
| 57 | regulation of mitochondrial translation (GO:0070129) | 2.73722606 |
| 58 | response to interferon-beta (GO:0035456) | 2.69535949 |
| 59 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.66669071 |
| 60 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.63169369 |
| 61 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.63169369 |
| 62 | neuron fate determination (GO:0048664) | 2.60703169 |
| 63 | negative regulation of membrane potential (GO:0045837) | 2.60593963 |
| 64 | positive regulation of T cell apoptotic process (GO:0070234) | 2.60538992 |
| 65 | cellular response to interferon-beta (GO:0035458) | 2.60525485 |
| 66 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.58413119 |
| 67 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.57296341 |
| 68 | termination of RNA polymerase III transcription (GO:0006386) | 2.56124178 |
| 69 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.56124178 |
| 70 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.55827607 |
| 71 | respiratory chain complex IV assembly (GO:0008535) | 2.55041716 |
| 72 | response to gravity (GO:0009629) | 2.54616583 |
| 73 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.54526778 |
| 74 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.54526778 |
| 75 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.54255247 |
| 76 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.53596386 |
| 77 | macrophage chemotaxis (GO:0048246) | 2.52916979 |
| 78 | mannosylation (GO:0097502) | 2.52221794 |
| 79 | base-excision repair, AP site formation (GO:0006285) | 2.51654387 |
| 80 | GTP biosynthetic process (GO:0006183) | 2.45380684 |
| 81 | deoxyribose phosphate catabolic process (GO:0046386) | 2.45216428 |
| 82 | negative regulation of appetite (GO:0032099) | 2.45152433 |
| 83 | negative regulation of response to food (GO:0032096) | 2.45152433 |
| 84 | inner mitochondrial membrane organization (GO:0007007) | 2.43484787 |
| 85 | protein targeting to membrane (GO:0006612) | 2.43431962 |
| 86 | anterograde synaptic vesicle transport (GO:0048490) | 2.43201579 |
| 87 | viral protein processing (GO:0019082) | 2.43156921 |
| 88 | intracellular protein transmembrane import (GO:0044743) | 2.40270550 |
| 89 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.38396352 |
| 90 | negative regulation of cation channel activity (GO:2001258) | 2.38037682 |
| 91 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.37378431 |
| 92 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.35992267 |
| 93 | regulation of mononuclear cell migration (GO:0071675) | 2.34413497 |
| 94 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.33897562 |
| 95 | protein-cofactor linkage (GO:0018065) | 2.30706919 |
| 96 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.28775615 |
| 97 | translation (GO:0006412) | 2.28725107 |
| 98 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.27830962 |
| 99 | glycerophospholipid catabolic process (GO:0046475) | 2.25962989 |
| 100 | epithelial cilium movement (GO:0003351) | 2.25645884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.70750122 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.47847286 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.13490661 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.94227763 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.73711908 |
| 6 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.70743158 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.70325631 |
| 8 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.65144098 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.50822172 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.39893709 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.38042095 |
| 12 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.29947763 |
| 13 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11156106 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.08195929 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.07659589 |
| 16 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.02402120 |
| 17 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.02060850 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.96321582 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.88989274 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.75898372 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.66967927 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.66702155 |
| 23 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.62269383 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.59918765 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58796975 |
| 26 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.57484988 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55289575 |
| 28 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.40290577 |
| 29 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.39069419 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38772284 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.37024008 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.36655928 |
| 33 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.36066860 |
| 34 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.35042115 |
| 35 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.34011402 |
| 36 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.33648720 |
| 37 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.33616518 |
| 38 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.32270076 |
| 39 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 1.29212631 |
| 40 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.28514824 |
| 41 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.27561983 |
| 42 | VDR_22108803_ChIP-Seq_LS180_Human | 1.27524166 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.26613185 |
| 44 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.26086359 |
| 45 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.25874785 |
| 46 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.25853145 |
| 47 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.23927573 |
| 48 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.22675768 |
| 49 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.22486734 |
| 50 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.21382435 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.20503329 |
| 52 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.19632363 |
| 53 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.19188566 |
| 54 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.18638469 |
| 55 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.18567849 |
| 56 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.18455327 |
| 57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.14605858 |
| 58 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.14542007 |
| 59 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.14330105 |
| 60 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.11615427 |
| 61 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11106260 |
| 62 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.10625277 |
| 63 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.09243250 |
| 64 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.08699193 |
| 65 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07845937 |
| 66 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.06833689 |
| 67 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.06588763 |
| 68 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05297667 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05251898 |
| 70 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05163047 |
| 71 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.04446186 |
| 72 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.04321479 |
| 73 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.03878622 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03259393 |
| 75 | AR_20517297_ChIP-Seq_VCAP_Human | 1.01979917 |
| 76 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.99467619 |
| 77 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.99467619 |
| 78 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.99072537 |
| 79 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.97671289 |
| 80 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97560053 |
| 81 | NCOR_22424771_ChIP-Seq_293T_Human | 0.96928407 |
| 82 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.96755987 |
| 83 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.96550095 |
| 84 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.96490894 |
| 85 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.95894652 |
| 86 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.95203485 |
| 87 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.94918743 |
| 88 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.94672888 |
| 89 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.93981801 |
| 90 | P300_27268052_Chip-Seq_Bcells_Human | 0.93089566 |
| 91 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.93014001 |
| 92 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.93014001 |
| 93 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.92971529 |
| 94 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.92192730 |
| 95 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.90950356 |
| 96 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.90821562 |
| 97 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90179387 |
| 98 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89854215 |
| 99 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.88965010 |
| 100 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.88715455 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 3.57050108 |
| 2 | MP0009379_abnormal_foot_pigmentation | 3.46286094 |
| 3 | MP0003011_delayed_dark_adaptation | 2.44528589 |
| 4 | MP0001905_abnormal_dopamine_level | 2.38340900 |
| 5 | MP0003880_abnormal_central_pattern | 2.14176512 |
| 6 | MP0005671_abnormal_response_to | 2.12394357 |
| 7 | MP0003136_yellow_coat_color | 2.00805037 |
| 8 | MP0006082_CNS_inflammation | 1.98198527 |
| 9 | MP0000343_altered_response_to | 1.94187361 |
| 10 | MP0003186_abnormal_redox_activity | 1.89400627 |
| 11 | MP0005084_abnormal_gallbladder_morpholo | 1.86466061 |
| 12 | MP0010386_abnormal_urinary_bladder | 1.85811765 |
| 13 | MP0006072_abnormal_retinal_apoptosis | 1.80376742 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 1.80149772 |
| 15 | MP0005058_abnormal_lysosome_morphology | 1.73695333 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 1.73279420 |
| 17 | MP0003122_maternal_imprinting | 1.71544633 |
| 18 | MP0001970_abnormal_pain_threshold | 1.69230006 |
| 19 | MP0001984_abnormal_olfaction | 1.68989573 |
| 20 | MP0002163_abnormal_gland_morphology | 1.68720648 |
| 21 | MP0003123_paternal_imprinting | 1.68679327 |
| 22 | MP0000372_irregular_coat_pigmentation | 1.67553528 |
| 23 | MP0003787_abnormal_imprinting | 1.66923177 |
| 24 | MP0009046_muscle_twitch | 1.63138289 |
| 25 | MP0009785_altered_susceptibility_to | 1.56486401 |
| 26 | MP0004142_abnormal_muscle_tone | 1.56414298 |
| 27 | MP0001542_abnormal_bone_strength | 1.56278975 |
| 28 | MP0002736_abnormal_nociception_after | 1.48983087 |
| 29 | MP0001968_abnormal_touch/_nociception | 1.46882272 |
| 30 | MP0002638_abnormal_pupillary_reflex | 1.45621984 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.44866674 |
| 32 | MP0009745_abnormal_behavioral_response | 1.42467315 |
| 33 | MP0006292_abnormal_olfactory_placode | 1.41442321 |
| 34 | MP0003075_altered_response_to | 1.39844978 |
| 35 | MP0002733_abnormal_thermal_nociception | 1.39541626 |
| 36 | MP0005551_abnormal_eye_electrophysiolog | 1.39347194 |
| 37 | MP0002653_abnormal_ependyma_morphology | 1.35734132 |
| 38 | MP0009764_decreased_sensitivity_to | 1.35218710 |
| 39 | MP0005379_endocrine/exocrine_gland_phen | 1.32261303 |
| 40 | MP0002095_abnormal_skin_pigmentation | 1.30743963 |
| 41 | MP0006276_abnormal_autonomic_nervous | 1.30658960 |
| 42 | MP0004742_abnormal_vestibular_system | 1.29550736 |
| 43 | MP0001485_abnormal_pinna_reflex | 1.27538752 |
| 44 | MP0002272_abnormal_nervous_system | 1.23493972 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.23051960 |
| 46 | MP0002277_abnormal_respiratory_mucosa | 1.21982994 |
| 47 | MP0001529_abnormal_vocalization | 1.21706960 |
| 48 | MP0008789_abnormal_olfactory_epithelium | 1.20374345 |
| 49 | MP0002064_seizures | 1.19591446 |
| 50 | MP0002295_abnormal_pulmonary_circulatio | 1.18102967 |
| 51 | MP0005174_abnormal_tail_pigmentation | 1.17581925 |
| 52 | MP0003121_genomic_imprinting | 1.16820858 |
| 53 | MP0004510_myositis | 1.15105273 |
| 54 | MP0001835_abnormal_antigen_presentation | 1.12380333 |
| 55 | MP0005000_abnormal_immune_tolerance | 1.10634603 |
| 56 | MP0006036_abnormal_mitochondrial_physio | 1.10482639 |
| 57 | MP0005253_abnormal_eye_physiology | 1.09915795 |
| 58 | MP0002938_white_spotting | 1.07954148 |
| 59 | MP0005645_abnormal_hypothalamus_physiol | 1.07632400 |
| 60 | MP0002572_abnormal_emotion/affect_behav | 1.07405109 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.04775001 |
| 62 | MP0001756_abnormal_urination | 1.04369655 |
| 63 | MP0002735_abnormal_chemical_nociception | 1.02053247 |
| 64 | MP0002557_abnormal_social/conspecific_i | 1.00716793 |
| 65 | MP0005025_abnormal_response_to | 0.99654564 |
| 66 | MP0000230_abnormal_systemic_arterial | 0.99439215 |
| 67 | MP0000026_abnormal_inner_ear | 0.97251535 |
| 68 | MP0005387_immune_system_phenotype | 0.96481222 |
| 69 | MP0001790_abnormal_immune_system | 0.96481222 |
| 70 | MP0002822_catalepsy | 0.95757729 |
| 71 | MP0002090_abnormal_vision | 0.95634278 |
| 72 | MP0005171_absent_coat_pigmentation | 0.95446261 |
| 73 | MP0003172_abnormal_lysosome_physiology | 0.95405019 |
| 74 | MP0002693_abnormal_pancreas_physiology | 0.92731708 |
| 75 | MP0001486_abnormal_startle_reflex | 0.91655813 |
| 76 | MP0001963_abnormal_hearing_physiology | 0.88902738 |
| 77 | MP0003646_muscle_fatigue | 0.88612689 |
| 78 | MP0001853_heart_inflammation | 0.86524419 |
| 79 | MP0006054_spinal_hemorrhage | 0.85260728 |
| 80 | MP0003633_abnormal_nervous_system | 0.84611099 |
| 81 | MP0005423_abnormal_somatic_nervous | 0.84263650 |
| 82 | MP0002102_abnormal_ear_morphology | 0.84071325 |
| 83 | MP0005503_abnormal_tendon_morphology | 0.83353992 |
| 84 | MP0001986_abnormal_taste_sensitivity | 0.82412656 |
| 85 | MP0001845_abnormal_inflammatory_respons | 0.82048902 |
| 86 | MP0000639_abnormal_adrenal_gland | 0.81327301 |
| 87 | MP0002909_abnormal_adrenal_gland | 0.81203447 |
| 88 | MP0010030_abnormal_orbit_morphology | 0.79896713 |
| 89 | MP0002234_abnormal_pharynx_morphology | 0.79302837 |
| 90 | MP0002723_abnormal_immune_serum | 0.78183212 |
| 91 | MP0002282_abnormal_trachea_morphology | 0.77954651 |
| 92 | MP0005075_abnormal_melanosome_morpholog | 0.74465567 |
| 93 | MP0002734_abnormal_mechanical_nocicepti | 0.74119284 |
| 94 | MP0002067_abnormal_sensory_capabilities | 0.71978805 |
| 95 | MP0005332_abnormal_amino_acid | 0.70585634 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.70377294 |
| 97 | MP0003195_calcinosis | 0.69774201 |
| 98 | MP0002063_abnormal_learning/memory/cond | 0.69742049 |
| 99 | MP0008872_abnormal_physiological_respon | 0.69340170 |
| 100 | MP0004145_abnormal_muscle_electrophysio | 0.69248106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.63869549 |
| 2 | Mitochondrial inheritance (HP:0001427) | 5.41609278 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.28346072 |
| 4 | Progressive macrocephaly (HP:0004481) | 4.91384629 |
| 5 | Hepatocellular necrosis (HP:0001404) | 4.65288560 |
| 6 | Renal Fanconi syndrome (HP:0001994) | 4.53941470 |
| 7 | Acute encephalopathy (HP:0006846) | 4.51786750 |
| 8 | Increased CSF lactate (HP:0002490) | 4.39512182 |
| 9 | Hepatic necrosis (HP:0002605) | 4.32208693 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 4.15426529 |
| 11 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.97973161 |
| 12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.97973161 |
| 13 | 3-Methylglutaconic aciduria (HP:0003535) | 3.90949807 |
| 14 | Increased intramyocellular lipid droplets (HP:0012240) | 3.79603898 |
| 15 | Lipid accumulation in hepatocytes (HP:0006561) | 3.69551336 |
| 16 | Exertional dyspnea (HP:0002875) | 3.33701153 |
| 17 | Cerebral edema (HP:0002181) | 3.24639344 |
| 18 | Increased muscle lipid content (HP:0009058) | 3.16779773 |
| 19 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.06107985 |
| 20 | Respiratory failure (HP:0002878) | 2.93121146 |
| 21 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.90034191 |
| 22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.90034191 |
| 23 | Abnormality of glycolipid metabolism (HP:0010969) | 2.90034191 |
| 24 | Myokymia (HP:0002411) | 2.86974137 |
| 25 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.85564401 |
| 26 | Abnormality of renal resorption (HP:0011038) | 2.83934825 |
| 27 | Abnormal number of erythroid precursors (HP:0012131) | 2.80465261 |
| 28 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.79809981 |
| 29 | True hermaphroditism (HP:0010459) | 2.76840677 |
| 30 | Abnormality of midbrain morphology (HP:0002418) | 2.76704368 |
| 31 | Molar tooth sign on MRI (HP:0002419) | 2.76704368 |
| 32 | Optic disc pallor (HP:0000543) | 2.73961987 |
| 33 | Congenital, generalized hypertrichosis (HP:0004540) | 2.68125663 |
| 34 | Generalized aminoaciduria (HP:0002909) | 2.66761954 |
| 35 | Polyphagia (HP:0002591) | 2.66566159 |
| 36 | Lactic acidosis (HP:0003128) | 2.59681956 |
| 37 | Pancreatic fibrosis (HP:0100732) | 2.59468123 |
| 38 | Vacuolated lymphocytes (HP:0001922) | 2.58486568 |
| 39 | Exercise intolerance (HP:0003546) | 2.53404597 |
| 40 | Medial flaring of the eyebrow (HP:0010747) | 2.49258004 |
| 41 | Prolonged neonatal jaundice (HP:0006579) | 2.47543354 |
| 42 | Petechiae (HP:0000967) | 2.46666681 |
| 43 | Pancreatic cysts (HP:0001737) | 2.39501848 |
| 44 | Methylmalonic aciduria (HP:0012120) | 2.38174444 |
| 45 | Reticulocytopenia (HP:0001896) | 2.34864232 |
| 46 | Abnormality of urine glucose concentration (HP:0011016) | 2.33885605 |
| 47 | Glycosuria (HP:0003076) | 2.33885605 |
| 48 | Agitation (HP:0000713) | 2.25981487 |
| 49 | Increased serum lactate (HP:0002151) | 2.22829708 |
| 50 | Leukodystrophy (HP:0002415) | 2.22681224 |
| 51 | Nephronophthisis (HP:0000090) | 2.22279533 |
| 52 | Sclerocornea (HP:0000647) | 2.19626796 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.15220944 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.15220944 |
| 55 | Cutaneous melanoma (HP:0012056) | 2.11103871 |
| 56 | Dysostosis multiplex (HP:0000943) | 2.08473395 |
| 57 | Aplastic anemia (HP:0001915) | 2.08031132 |
| 58 | Lethargy (HP:0001254) | 2.05830244 |
| 59 | Septo-optic dysplasia (HP:0100842) | 1.99667534 |
| 60 | Methylmalonic acidemia (HP:0002912) | 1.99046783 |
| 61 | Focal dystonia (HP:0004373) | 1.98631410 |
| 62 | Severe visual impairment (HP:0001141) | 1.98420354 |
| 63 | Emotional lability (HP:0000712) | 1.93957196 |
| 64 | Type I transferrin isoform profile (HP:0003642) | 1.92691758 |
| 65 | Respiratory difficulties (HP:0002880) | 1.91371056 |
| 66 | Progressive neurologic deterioration (HP:0002344) | 1.91081754 |
| 67 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.90867346 |
| 68 | CNS demyelination (HP:0007305) | 1.90519202 |
| 69 | X-linked dominant inheritance (HP:0001423) | 1.89086953 |
| 70 | Macrocytic anemia (HP:0001972) | 1.88445743 |
| 71 | Hemiparesis (HP:0001269) | 1.86509629 |
| 72 | Purpura (HP:0000979) | 1.84190224 |
| 73 | Hyperphosphaturia (HP:0003109) | 1.82553220 |
| 74 | Abnormality of macrophages (HP:0004311) | 1.81389776 |
| 75 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.80910934 |
| 76 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.79862532 |
| 77 | Craniofacial dystonia (HP:0012179) | 1.78944668 |
| 78 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.78543029 |
| 79 | Albinism (HP:0001022) | 1.77843504 |
| 80 | Congenital stationary night blindness (HP:0007642) | 1.77265560 |
| 81 | Gait imbalance (HP:0002141) | 1.76087299 |
| 82 | Congenital primary aphakia (HP:0007707) | 1.75101861 |
| 83 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.74693598 |
| 84 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.74596516 |
| 85 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.74295636 |
| 86 | Irregular vertebral endplates (HP:0003301) | 1.70013363 |
| 87 | Axonal loss (HP:0003447) | 1.69253423 |
| 88 | Nephrogenic diabetes insipidus (HP:0009806) | 1.66896267 |
| 89 | Hyperglycinemia (HP:0002154) | 1.65455936 |
| 90 | Increased IgM level (HP:0003496) | 1.65136330 |
| 91 | Hypoalbuminemia (HP:0003073) | 1.64554420 |
| 92 | Abnormal albumin level (HP:0012116) | 1.64554420 |
| 93 | Abnormal eating behavior (HP:0100738) | 1.63425615 |
| 94 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.62526533 |
| 95 | Decreased central vision (HP:0007663) | 1.59695187 |
| 96 | Blindness (HP:0000618) | 1.59618412 |
| 97 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.59401662 |
| 98 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.59401662 |
| 99 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.58195006 |
| 100 | Progressive microcephaly (HP:0000253) | 1.55947915 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.73124754 |
| 2 | BCKDK | 3.22589923 |
| 3 | LIMK1 | 2.88433313 |
| 4 | STK16 | 2.83707236 |
| 5 | TESK2 | 2.44966592 |
| 6 | TESK1 | 2.36818789 |
| 7 | EPHB2 | 2.31938425 |
| 8 | MAP3K12 | 2.22016912 |
| 9 | ADRBK2 | 2.20262783 |
| 10 | MAP4K2 | 2.16684537 |
| 11 | FRK | 2.00418612 |
| 12 | VRK1 | 1.99976610 |
| 13 | MYLK | 1.97831732 |
| 14 | NME2 | 1.92570249 |
| 15 | PIM2 | 1.89771339 |
| 16 | MAP3K11 | 1.87091862 |
| 17 | TXK | 1.74876465 |
| 18 | ZAK | 1.73095542 |
| 19 | GRK7 | 1.68801480 |
| 20 | KDR | 1.63099278 |
| 21 | TLK1 | 1.61708026 |
| 22 | GRK1 | 1.59131358 |
| 23 | CDK19 | 1.54478393 |
| 24 | DYRK2 | 1.54417082 |
| 25 | MAP2K7 | 1.54053636 |
| 26 | NUAK1 | 1.52689332 |
| 27 | ABL2 | 1.46024588 |
| 28 | PINK1 | 1.41939817 |
| 29 | CSNK1G3 | 1.37255619 |
| 30 | ARAF | 1.36837697 |
| 31 | DAPK3 | 1.35244605 |
| 32 | CAMKK2 | 1.32036804 |
| 33 | CSNK1G2 | 1.23358499 |
| 34 | PRKD3 | 1.17250042 |
| 35 | MST4 | 1.17176132 |
| 36 | MAPK15 | 1.16942072 |
| 37 | GRK5 | 1.16324284 |
| 38 | IKBKB | 1.12487425 |
| 39 | BMPR1B | 1.10163512 |
| 40 | ADRBK1 | 1.07540321 |
| 41 | CSNK1G1 | 1.03074925 |
| 42 | TAOK3 | 0.94871834 |
| 43 | CSNK1A1L | 0.93995560 |
| 44 | TBK1 | 0.89675061 |
| 45 | ILK | 0.88291998 |
| 46 | WNK3 | 0.87845817 |
| 47 | PRKCG | 0.87255385 |
| 48 | TAOK2 | 0.85535946 |
| 49 | PAK3 | 0.83794823 |
| 50 | EPHA4 | 0.82530312 |
| 51 | MAPKAPK3 | 0.80611450 |
| 52 | DAPK2 | 0.78909776 |
| 53 | LRRK2 | 0.76121392 |
| 54 | PRKCQ | 0.74808659 |
| 55 | IKBKE | 0.73249215 |
| 56 | INSRR | 0.72006099 |
| 57 | MUSK | 0.68116641 |
| 58 | DAPK1 | 0.67038333 |
| 59 | SYK | 0.66663853 |
| 60 | LMTK2 | 0.66087129 |
| 61 | PRKCE | 0.65845785 |
| 62 | KIT | 0.63335469 |
| 63 | PAK1 | 0.63258078 |
| 64 | PHKG1 | 0.62941081 |
| 65 | PHKG2 | 0.62941081 |
| 66 | TNK2 | 0.62870038 |
| 67 | PTK2B | 0.59423393 |
| 68 | ROCK1 | 0.58981362 |
| 69 | PLK2 | 0.58904935 |
| 70 | MAP3K4 | 0.58683922 |
| 71 | NTRK2 | 0.57711074 |
| 72 | MAP2K6 | 0.57676610 |
| 73 | PKN1 | 0.55974856 |
| 74 | MAPK13 | 0.55966013 |
| 75 | RPS6KA5 | 0.55832408 |
| 76 | CAMK2D | 0.54187503 |
| 77 | DDR2 | 0.53231896 |
| 78 | PNCK | 0.50717472 |
| 79 | ITK | 0.49878610 |
| 80 | CAMK2G | 0.49807161 |
| 81 | FES | 0.49153020 |
| 82 | FGFR2 | 0.48181119 |
| 83 | TAF1 | 0.47716738 |
| 84 | PRKCD | 0.46691499 |
| 85 | LYN | 0.46655359 |
| 86 | PRKACA | 0.44508673 |
| 87 | CSNK1A1 | 0.44308205 |
| 88 | PRKCA | 0.43775241 |
| 89 | MINK1 | 0.43684978 |
| 90 | AURKA | 0.43656912 |
| 91 | PIK3CG | 0.43248630 |
| 92 | CAMK1 | 0.42469973 |
| 93 | CAMK2A | 0.42188963 |
| 94 | MAPKAPK5 | 0.40620499 |
| 95 | MARK1 | 0.35213958 |
| 96 | TIE1 | 0.34569585 |
| 97 | TEC | 0.33758633 |
| 98 | WNK4 | 0.33061554 |
| 99 | CASK | 0.32362597 |
| 100 | TGFBR2 | 0.31291634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.69261849 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.55827411 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.72231248 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.22520338 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 3.21340767 |
| 6 | Huntingtons disease_Homo sapiens_hsa05016 | 2.99642357 |
| 7 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.90630257 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.68527185 |
| 9 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.60587263 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.06904855 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.91419804 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.83516016 |
| 13 | RNA polymerase_Homo sapiens_hsa03020 | 1.75886892 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.69422049 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.60938203 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.55496270 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.54652146 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.50052256 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.49543974 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.48246823 |
| 21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.46318611 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.42404702 |
| 23 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.41799149 |
| 24 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.38544776 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33051513 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.29656189 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.19981196 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14606421 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.11781309 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.11669300 |
| 31 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.11261089 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.08348622 |
| 33 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.08288758 |
| 34 | Phototransduction_Homo sapiens_hsa04744 | 1.04703177 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.01552924 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.00052843 |
| 37 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.99583210 |
| 38 | Sulfur relay system_Homo sapiens_hsa04122 | 0.98579278 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90108267 |
| 40 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.89079032 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85904896 |
| 42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84556500 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.82304654 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80194113 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79127686 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.78576175 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77300062 |
| 48 | Phagosome_Homo sapiens_hsa04145 | 0.75832571 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 0.73704441 |
| 50 | Metabolic pathways_Homo sapiens_hsa01100 | 0.70473359 |
| 51 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.67197036 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64979652 |
| 53 | Nicotine addiction_Homo sapiens_hsa05033 | 0.64101219 |
| 54 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63680750 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.62663279 |
| 56 | Purine metabolism_Homo sapiens_hsa00230 | 0.62284204 |
| 57 | Mineral absorption_Homo sapiens_hsa04978 | 0.61304489 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61116143 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60528106 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60097425 |
| 61 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59623654 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59124733 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58255560 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.55799739 |
| 65 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55630501 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53556803 |
| 67 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50963531 |
| 68 | GABAergic synapse_Homo sapiens_hsa04727 | 0.50454584 |
| 69 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49351292 |
| 70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.46369809 |
| 71 | Homologous recombination_Homo sapiens_hsa03440 | 0.46121376 |
| 72 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45453115 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44766058 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44101838 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42292305 |
| 76 | Morphine addiction_Homo sapiens_hsa05032 | 0.41799856 |
| 77 | Malaria_Homo sapiens_hsa05144 | 0.41721478 |
| 78 | Pertussis_Homo sapiens_hsa05133 | 0.40248176 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35556163 |
| 80 | Salivary secretion_Homo sapiens_hsa04970 | 0.34340991 |
| 81 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.33653851 |
| 82 | Insulin secretion_Homo sapiens_hsa04911 | 0.33153968 |
| 83 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.32499077 |
| 84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.31618707 |
| 85 | Alcoholism_Homo sapiens_hsa05034 | 0.31417877 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30575959 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30110595 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.29605029 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.27918979 |
| 90 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.27733875 |
| 91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.27129507 |
| 92 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.24778086 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.24774309 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.23201960 |
| 95 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.22558781 |
| 96 | Circadian entrainment_Homo sapiens_hsa04713 | 0.21813501 |
| 97 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.19818687 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19729203 |
| 99 | Cocaine addiction_Homo sapiens_hsa05030 | 0.19082136 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.18048961 |

